AMA CPT® Assistant - 2021 Issue 9 (September)
Reporting Manual Preparation and Insertion or Removal of Musculoskeletal Drug-Delivery Devices
Reporting Manual Preparation and Insertion or Removal of Musculoskeletal Drug-Delivery Devices Prior to 2020, the Current Procedural Terminology (CPT ® ) codes for the insertion ( 11981 ), removal ( 11982 ), and removal with reinsertion ( 11983 ) of nonbiodegradable drug-delivery devices were described in generic and general terms. Many medical specialty societies reported these codes and the differences in the amount and intensity of work were significant. For example, because infection is one of the most common, potential complications in musculoskeletal procedures, including total joint arthroplasty (TJA), physicians specializing in orthopedics were the principal reporters of these...
Subscribe or sign in to view the full article.
Article Overview
This article reviews orthopedic coding guidance for musculoskeletal drug-delivery device procedures and how they relate to infected joint and bone cases, including total joint arthroplasty scenarios. It is aimed at coders, orthopedic practices, and other reimbursement professionals who need to understand the CPT framework, add-on code structure, and documentation themes discussed for these services.
Why This Topic Matters
These procedures can overlap with other orthopedic operations and staged revision work, so accurate reporting depends on understanding how the CPT framework organizes the device-related services and related operative documentation. The article helps readers determine whether the topic matches their coding and documentation needs for musculoskeletal infection cases.
Article Sections
-
Introduction or Removal
Provides the overall CPT context for musculoskeletal drug-delivery device services and introduces the add-on code framework used in orthopedic surgery. It also summarizes the broad categories of procedures covered in the article.
-
Reporting Scenarios
Reviews general orthopedic situations in which manually prepared drug-delivery devices are implanted or removed in deep tissue, intramedullary, and intra-articular settings. The section also distinguishes these scenarios from other common device-related services.
-
Clinical Scenarios and TJAs
Introduces common total joint arthroplasty infection scenarios in which drug-delivery devices may be used. It sets up the more detailed case-based coding discussion that follows.
-
Scenario 1a: Infected TJA; Irrigation and Debridement Only
Describes one infected joint arthroplasty scenario involving debridement-focused care and the related reporting considerations. The discussion stays centered on the procedure type and the broad role of drug-delivery devices.
-
Scenario 1b: Infected TJA; Revision Arthroplasty With Placement of Modular Articular Components
Covers a revision arthroplasty scenario with modular component work and the associated documentation focus. The section also notes how intra-articular device services may intersect with the revision procedure.
-
Scenario 2: Complete Removal of an Infected TJA (Resection Arthroplasty) With Placement of an Intra-Articular Drug-Delivery Device as a Planned Staged Procedure
Addresses a staged resection arthroplasty situation involving removal of infected joint implants and placement of an intra-articular device. It emphasizes the general distinction between resection and later reconstruction.
-
Scenario 3: Complete Joint Implant Replacement (Revision Arthroplasty or Articulating Spacers); May or May Not be Part of a Planned Staged Procedure
Explains a full joint replacement scenario after infection treatment and discusses how revision-type procedures are differentiated from other implant management approaches. The section also highlights the role of device preparation in this setting.
-
Scenario 4: Staged or Delayed Removal of Intra-Articular Drug-Delivery Device(s)
Discusses delayed device removal in the context of staged reconstruction or secondary revision after infection treatment. It also covers timing and postoperative-period considerations at a high level.
-
Documentation of Drug-Delivery Implantation Codes
Summarizes the documentation themes needed to support reporting of these orthopedic device services. The section focuses on operative note content and how the procedure record should reflect the work performed.
What You Will Learn
- How musculoskeletal drug-delivery device services are organized within the CPT framework
- Which broad orthopedic procedure categories are discussed in relation to infected joints and bones
- How staged arthroplasty scenarios are presented in the article
- What types of operative documentation themes are emphasized for these services
- How add-on code reporting is discussed at a high level in relation to primary procedures
Who Should Read This
- Orthopedic surgeons
- Professional coders
- Billing and reimbursement staff
- Clinical documentation specialists
- Practice administrators
Codes Discussed
Code Ranges Discussed
Modifiers Discussed
Subscribe or sign in to view the full article.


Quick, Current, Complete - www.findacode.com